Skip to main content
[Translate to English:]

Novo Nordisk Pharma GmbH

Dr. Robert Haustein, Senior Manager Govermental Affairs, Head of Capital Office, Novo Nordisk Pharma GmbH

 

1. Describe your company in a Tweet! 

Novo Nordisk is a global leader in healthcare, founded in 1923 and headquartered in Denmark. We drive change with the goal of defeating diabetes and other serious chronic diseases such as obesity and rare blood and metabolic disorders. To do this, we are working on breakthrough scientific innovations to the point of curing diseases. We promote access to our products for patients worldwide and are actively engaged in prevention. Novo Nordisk employs around 45,000 people in 80 countries and markets its products in around 170 countries. Around 480 employees work at the German headquarters in Mainz.

 

2. Why do you get involved as a Berlin Partner? 

As an internationally active company with Danish roots, we are convinced of Berlin and its importance for the healthcare industry in Germany and Europe.

 

Exclusive information for Berlin-Partners

Photocredit: © Novo Nordisk

TeilenShare

Weitere
Informationen
Further
Information

Creations for a greener future

16.06.2023
Berlin and Brandenburg present themselves at the 5th Greentech Festival in the Urban Tech Republic at the former Tegel Airport

Read more

Berlin is in anticipation

14.06.2023
Capital city as a sports metropolis: 7000 athletes from 190 countries will take part in the Special Olympics World Games

Read more

Capital City Electromobility Conference

01.06.2023
Peak in public charging points, E-mobility is picking up speed

Read more

Berlin is knorke: Making construction more climate-friendly

30.05.2023
Conserve resources and reduce CO2 emissions by reusing building materials

Read more

Solar energy meets design

16.05.2023
The combination of art and science that makes it possible to experience the power of the sun

Read more

Brain City Berlin - the city of bright minds

11.05.2023
What distinguishes Berlin as a place for science? An interview with Nobel Prize winner Professor Dr. Emmanuelle Charpentier

Read more